Nusano News
Nusano Announces In-House Stable Isotope Program Led by Renowned Physicist Sarko Cherekdjian
Nusano is creating an in-house stable isotope program to enhance the company’s medical radioisotope production capabilities and decrease dependence on foreign supply chains.
Nusano to Present Production Capabilities to European Radiopharmaceuticals Working Group
Nusano will present an overview of the company’s breakthrough production platform to the European Cooperation in Science and Technology (COST) Astatine-211 Working Group on May 4, 2023. Presentation materials will be available on the company’s website following the event.
Nusano Co-Founder Dr. Howard Lewin to Participate in Truist Securities Virtual Radiopharmaceuticals Event
Nusano’s Dr. Howard Lewin will take part in a virtual event hosted by Truist Securities on Friday, April 21, 2023, at 3:30 p.m. Eastern.
Nusano Announces Q1 2025 Opening Date for Medical Radioisotope Production Facility in Utah
Nusano’s breakthrough production facility will open Q1 2025 in West Valley City, Utah.
Industry News
Toronto Star: Sudden shortage of vital isotope hitting Canadian hospitals
Nov. 10, 2022 – The unexpected shut down of a nuclear reactor in Belgium is creating issues for patients in Canada...
U.S. investing in domestic isotope supply
Department of Energy Secretary Jennifer Granholm breaks ground on facility to provide radioisotopes vital to national security, research and health care.
University of Missouri responds to global radioisotope shortage
An unplanned production outage in Europe poses a threat to radioisotope supplies worldwide.
DISCOVER MORE ABOUT NUSANO
Sign up to receive company news and updates